Latest News
Bausch Health And BHVI Announce Exclusive Global Licensing Agreement For Myopia Control Contact Lens
Second Exclusive License Strengthens Bausch + Lomb’s Global Research Focus on Myopia SYDNEY, Australia and LAVAL, Quebec, Oct. 15, 2020 – Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and
Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: A Review
Senuri Karunaratne, BSc, OD BHVI Pathological myopia is characterized by excessive and progressive elongation of the globe leading to impaired vision and blindness. A common complication of pathological myopia is
Bausch Health And BHVI Announce Exclusive Global Licensing Agreement For Myopia Control Contact Lens
Second Exclusive License Strengthens Bausch + Lomb’s Global Research Focus on Myopia SYDNEY, Australia and LAVAL, Quebec, Oct. 15, 2020 – Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and Bausch + Lomb, its leading global eye health business, along with BHVI, an Australian not-for-profit organization with an international focus on vision research, announced today that
Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: A Review
Senuri Karunaratne, BSc, OD BHVI Pathological myopia is characterized by excessive and progressive elongation of the globe leading to impaired vision and blindness. A common complication of pathological myopia is choroidal neovascularisation, also referred to as myopic CNV. Recognizing a lack of clarity surrounding the epidemiology of pathological myopia, myopic CNV, and its impact upon vision,
Our Purpose
We fulfil unmet needs in the ophthalmic space by innovating commercially relevant technologies through to feasibility.
We generate ideas. We push the scientific envelope. We solve problems. We translate and communicate our knowledge. We look forward.
Our Values
Focused
We focus exclusively on research, development and ophthalmic sector support.
Innovative
We lead with industry, solving problems and creating technology. We bring new ideas to markets.
Dynamic
We focus on meeting unmet needs. We trial, test, learn, share and adapt.
Collaborative
We cannot achieve without each other; our team, our partners and our customers.